[Form 4] Medtronic plc Insider Trading Activity

Rhea-AI Filing Summary

Medtronic plc executive vice president for Global Operations & Supply Chain reported multiple open-market sales of company ordinary shares. On 11/19/2025, the officer sold several blocks of Medtronic stock at prices around $102 per share, reducing but not eliminating their direct stake. Following these transactions, the officer directly owned 46,016 ordinary shares.

The reported holdings also include 323 shares acquired through dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the prior report, showing ongoing participation in company equity programs alongside the sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Gregory L

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Global Ops & Supply Chain

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/19/2025		S		24,186	D	$101.93	51,830(1)	D
Ordinary Shares	11/19/2025		S		1,942	D	$101.99	49,888	D
Ordinary Shares	11/19/2025		S		1,995	D	$102.03	47,893	D
Ordinary Shares	11/19/2025		S		825	D	$102.04	47,068	D
Ordinary Shares	11/19/2025		S		227	D	$102.05	46,841	D
Ordinary Shares	11/19/2025		S		325	D	$102.06	46,516	D
Ordinary Shares	11/19/2025		S		500	D	$102.08	46,016	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 323 shares acquired through dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medtronic (MDT) report in this Form 4?

The filing shows Medtronic's EVP Global Operations & Supply Chain made multiple open-market sales of ordinary shares on 11/19/2025 at prices around $102 per share.

How many Medtronic (MDT) shares does the reporting person own after the transaction?

After the reported sales, the officer directly owned 46,016 ordinary shares of Medtronic.

What sale prices were reported for the Medtronic (MDT) insider trades?

The ordinary shares were sold in several transactions at prices ranging from $101.93 to $102.08 per share.

Who is the insider involved in this Medtronic (MDT) Form 4 filing and what is their role?

The reporting person is an officer of Medtronic, serving as EVP Global Ops & Supply Chain, and is reporting transactions in Medtronic ordinary shares.

Does the Form 4 show Medtronic (MDT) shares acquired through company programs?

Yes. The beneficial ownership figure includes 323 shares acquired via dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report.

Are the Medtronic (MDT) insider trades reported as direct or indirect ownership?

The ordinary shares listed in the table are shown as direct (D) ownership by the reporting officer.